Description of the medicine: Alveofakt (Alveofakt)
ALVEOFACT (Alveofakt) *.
Highly purified natural surfactant obtained from cattle lungs.
Suspension for intratracheal instillation.
The drug is proposed for use in respiratory failure syndrome (distress syndrome) in newborns (premature) associated with surfactant deficiency.
The drug is administered by intratracheal instillation.
Enter in the first hour after birth in a dose of 1, 2 ml per 1 kg of body weight, then, if necessary, repeat the introduction 3 more times on the following days - only 4 single doses.
Apply the drug in combination with artificial ventilation and other necessary means and methods of therapy.
Alveofact is a representative of a fundamentally new group of drugs in need of in-depth study. Currently, the search and study of new similar tools.